CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | Reardon Andrew CLO & Secretary | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,000 | 39,444 | ||
| 2026-05-27 | Espinoza Octavio Chief Financial Officer | Option exercise | +764 | $63.62 | $49K | 26,707 |
| 2026-05-27 | Espinoza Octavio Chief Financial Officer | Option exercise | +972 | $52.84 | $51K | 27,679 |
| 2026-05-27 | Espinoza Octavio Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −972 | 0 | ||
| 2026-05-27 | Espinoza Octavio Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −764 | 17,407 | ||
| 2026-05-13 | KOZARICH JOHN W Director | Option exercise 10b5-1 | +1,575 | $69.51 | $109K | 43,361 |
| 2026-05-13 | KOZARICH JOHN W Director | Sale 10b5-1 | −1,575 | $223.50 | $352K | 41,786 |
| 2026-05-13 | KOZARICH JOHN W Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,575 | 0 | ||
| 2026-05-12 | KOZARICH JOHN W Director | Option exercise 10b5-1 | +459 | $69.51 | $32K | 42,245 |
| 2026-05-12 | KOZARICH JOHN W Director | Sale 10b5-1 | −459 | $224.00 | $103K | 41,786 |
| 2026-05-12 | KOZARICH JOHN W Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −459 | 1,575 | ||
| 2026-05-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −80 | $227.37 | $18K | 42,173 |
| 2026-05-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −1 | $229.87 | $230 | 42,172 |
| 2026-05-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −165 | $231.87 | $38K | 42,007 |
| 2026-05-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −105 | $232.57 | $24K | 41,902 |
| 2026-05-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −116 | $234.09 | $27K | 41,786 |
| 2026-05-01 | Reardon Andrew CLO & Secretary | Option exercise 10b5-1 | +5,000 | $52.27 | $261K | 46,382 |
| 2026-05-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −600 | $227.45 | $136K | 45,782 |
| 2026-05-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −932 | $228.75 | $213K | 44,850 |
| 2026-05-01 | Reardon Andrew CLO & Secretary | Sale 10b5-1 | −98 | $229.71 | $23K | 44,752 |
Page 7 of 43 · 858 trades